Brief: VBL Therapeutics Announces First Patient In Europe In The OVAL Trial
29/12/2020 12:13
Dec 29 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS ANNOUNCES FIRST PATIENT IN EUROPE IN THE
OVAL
TRIAL
Source text for Eikon: ID:nGNX7NrHDg
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives